Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Top line data on the ATTRACT study
Idiopathic Pulmonary Fibrosis: 5 Things to Know
Patient insights to shape development of a dCBT for IPF patients